Test Price
2,800 AED✅ Home Collection Available
TMPO Gene Dilated Cardiomyopathy Type 1T (Genetic Test) in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Comprehensive post-test genetic counseling for expert result interpretation and familial risk assessment.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731; most major UAE insurers accepted.
Test Overview & Methodology
The TMPO gene test utilizes advanced Next-Generation Sequencing (NGS) to detect pathogenic mutations in the TMPO (thymopoietin) gene, which are responsible for familial dilated cardiomyopathy type 1T. This condition can lead to progressive heart failure, life-threatening arrhythmias, and sudden cardiac death. Early and accurate genetic identification enables proactive clinical surveillance, precise family risk stratification, and personalized management under the combined guidance of a cardiologist and a medical geneticist.
Comparative Technology Assessment
| Feature | Our NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | Analytical sensitivity >99.9% for single‑nucleotide variants and small indels; ACMG‑guided classification | ~95% sensitivity for targeted regions; limited variant interpretation |
| Method | Next‑Generation Sequencing (Illumina platform) with full coding exon and splice‑site coverage | Sanger (capillary) sequencing of selected exons only |
| Turnaround Time | 3 to 4 Weeks | 4 to 6 Weeks |
Physician Insight & Safety Protocols
“Understanding your genetic risk for cardiomyopathy can be life‑saving for you and your family. This test provides a crucial piece of the puzzle, but clinical correlation with cardiac imaging, electrocardiograms, and a thorough family history is essential for comprehensive management. Always consult your cardiologist before making any changes to your treatment plan.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Critical Patient Advisory
‼ Do not discontinue any prescribed medication without explicit advice from your treating physician. This genetic test is a risk assessment tool, not a replacement for ongoing clinical care.
Patient Safety – Exclusion Criteria & Emergency Red Flags
- This test is not intended for acute cardiac emergencies or for ruling out an ongoing heart failure episode.
- It should not be used as the sole diagnostic criterion for dilated cardiomyopathy; comprehensive imaging and clinical evaluation remain mandatory.
- The test is not validated for prenatal diagnosis unless explicitly approved by a clinical geneticist.
- If you experience severe chest pain, new-onset severe shortness of breath, fainting, or irregular palpitations, proceed to the nearest Emergency Department immediately – do not wait for test results.
Patient FAQ & Clinical Guidance
1. What is the TMPO gene dilated cardiomyopathy type 1T test?
The TMPO gene test is a next‑generation sequencing analysis that identifies pathogenic mutations in the TMPO gene linked to inherited dilated cardiomyopathy type 1T, providing critical data for early diagnosis and family risk stratification. It confirms the diagnosis in symptomatic patients or those with a significant family history and guides the screening of at-risk relatives.
2. How is the test performed and what preparation is needed?
The test requires a standard blood draw (EDTA), extracted DNA, or a single drop of blood on an FTA card. No fasting or special preparation is needed. A mandatory genetic counseling session is conducted beforehand to document the family pedigree and assess hereditary risk factors.
3. What do the results mean and what are the next steps?
A positive result indicates a known pathogenic TMPO mutation that increases lifetime risk for dilated cardiomyopathy, often necessitating regular cardiac surveillance and family screening. A negative result reduces but does not completely eliminate genetic risk due to the possibility of novel variants, and additional testing may be recommended based on your cardiologist’s guidance.
4. Who will have access to my genetic data?
Your genetic data is strictly confidential and handled in full compliance with UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL). Results are shared only with you and your designated healthcare providers. DNA Labs UAE does not share your genetic information with insurers or employers without your explicit written consent.
UAE Regulatory & Data Privacy Adherence
Your Trust is Our Priority. DNA Labs UAE operates under the strict oversight of the Dubai Health Authority (DHA License No: 1143). We adhere to the highest standards of data security and patient confidentiality as mandated by Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Our laboratory protocols are fully compliant with Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring safe, ethical, and accurate clinical testing.
Clinical & Logistical Metadata
| Test Name | TMPO Gene Dilated Cardiomyopathy Type 1T (Genetic Test) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) |
| Methodology Used | Next‑Generation Sequencing (NGS) with Full Coding Exon and Splice‑Site Coverage |
| ICD-10-CM Code | I42.0 (Dilated cardiomyopathy) |
| LOINC Code | 82186-6 (Dilated cardiomyopathy gene panel by Sequencing) |
| DHA Facility License & Address | DNA Labs UAE | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians